Hormone therapy is an important treatment for transgender and gender non-conforming individuals who feel uncomfortable with their gender. Before starting, talk to our specialists to understand and agree to the treatment. You'll typically need a referral letter. Here are the main criteria: - Diagnosi...
Hormone therapy for MtF patients is associated with an increased risk of thromboembolic disease, cholelithiasis, hyperprolactinemia, transaminitis, and triglyceride elevations. Masculinizing hormones in female-to-male (FtM) transgender patients are not associated with increased mortality, myocardial infarction ...
In the FtM cohort, there were significant increases in body mass index, creatinine, hemoglobin, and hematocrit. Although statistically significant, these changes were minimal for both cohorts.In our practice, hormone therapy was found to be safe in this retrospective study. 展开 ...
TherapyforTransgenders Do’sandDon'ts StevenM.Brown,MD UniversityofWisconsinSchoolofMedicine stevethediseaseslayer@yahoo ACaseReport WhatisHormone ReplacementTherapy? WhatisaHormone? Organiccompound,secretedbyagland,inminute quantities,intothebloodstream,thathasa ...
Both MtF and FtM transsexuals experience alterations in the serum lipid profile because of CSHT, with the changes in FtM patients possibly more relevant in terms of atherogenesis. © 2011 International Society for Sexual Medicine. Author supplied keywords Atherogenesis Cross-Sex Hormone Therapy Lipid...
Both MtF and FtM transsexuals experience alterations in the serum lipid profile because of CSHT, with the changes in FtM patients possibly more relevant in terms of atherogenesis. Ott J, Aust S, Promberger R, Huber JC, and Kaufmann U. Cross-sex hormone therapy alters the serum lipid profile...
BACKGROUND: Prior to the start of cross-sex hormone therapy (CSH), androgenic progestins are often used to induce amenorrhea in female to male (FtM) pubertal adolescents with gender dysphoria (GD). The aim of this single-center study is to report changes in anthropometry, side effects, safet...
changes attributed to high-dose cross-sex hormone therapy (HT) in male-to-female (MtF) and female to male (FtM) transgender patients by performing an oral glucose tolerance test (OGTT) and 3 Tesla magnet resonance spectroscopy for hepatic (HCL) and myocardial (MYCL) lipid content analysis. ...
70.Use of a mouse model of pancreatic neuroendocrine tumors to find pericyte biomarkers of resistance to anti-angiogenic therapy. 机译:胰腺神经内分泌肿瘤小鼠模型在寻找对抗血管生成疗法有抗性的周细胞生物标记中的应用。 作者:Franco M;Paez Ribes M;Cortez E;Casanovas O;Pietras K 期刊名称:《Hormone ...
been demonstrated in samples of postmenopausal women receiving estrogen replacement therapy resulting in an Scientific Reports | 6:37005 | DOI: 10.1038/srep37005 6 www.nature.com/scientificreports/ Figure 3. Changes of absolute metabolite concentrations in FtM and MtF following 12 months of CSH....